Denka Company Limited (DENKF)
Denka Company Limited operates in the Chemicals industry of the Basic Materials sector, headquartered in Tokyo, TY, JP. The stock last traded at $28.00, up 0.00% on the session, giving a market capitalisation of $2.41B. On trailing twelve-month figures it carries a trailing P/E of 22.90, a net margin of 3.5%. Its beta of 0.29 implies it has historically moved less than the broad market.
Denka Company Limited, an enterprise based in Tokyo, Japan, and established in 1915, operates as a global producer and purveyor of a diverse range of organic and inorganic materials. Its extensive product portfolio caters primarily to the electronics and pharmaceutical sectors. The company's operations are segmented into several key divisions. The Electronics & Innovative Products segment is dedicated to developing and supplying advanced components such as conductive agents crucial for lithium-ion batteries, along with thermal management materials, specialized substrates, high-performance ceramics, and various films and tapes. Under its Life Innovation division, Denka plays a significant role in public health, offering influenza vaccines, producing rapid diagnostic kits – including those for identifying novel coronavirus antigens – and providing macromolecular sodium hyaluronate preparations. The Elastomers & Infrastructure Solutions arm encompasses a variety of products, ranging from specialized functional elastomers and cement additives to agricultural essentials like fertilizers and corrugated pipes. Finally, the Polymer Solutions division focuses on synthetic materials, featuring styrene-based resins, food packaging sheets, and synthetic fibers utilized in wigs and hairpieces, alongside poval and other diverse chemical offerings. Originally founded in 1915 as Denki Kagaku Kogyo Kabushiki Kaisha, the company adopted its current name, Denka Company Limited, in October 2015.
Denka Company Limited is most often compared with the following Basic Materials names: